1-3 of 3
Teresa Cirulli
Close
Sort by
Journal Articles

Validation of PDGFRβ and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib

Addolorata Maria Luce Coluccia, Teresa Cirulli, Paola Neri, Domenica Mangieri, Maria Cristina Colanardi, Antonio Gnoni, Nicola Di Renzo, Franco Dammacco, Pierfrancesco Tassone, Domenico Ribatti, Carlo Gambacorti-Passerini, Angelo Vacca
Journal: Blood
Blood (2008) 112 (4): 1346–1356.
https://doi.org/10.1182/blood-2007-10-116590
Published: 2008
Journal Articles

Dasatinib Inhibits Multiple Myeloma Growth by Blocking PDGF-Rb and c-Src Activity in Patient-Derived Tumor and Endothelial Cells.

Addolorata M.L. Coluccia, PhD, Teresa Cirulli, Paola Neri, Franco Dammacco, MD, Pierfrancesco Tassone, PhD, Carlo Gambacorti, MD, Angelo Vacca, MD
Journal: Blood
Blood (2007) 110 (11): 550.
https://doi.org/10.1182/blood.V110.11.550.550
Published: 2007
Journal Articles

Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma

Angelo Vacca, Claudio Scavelli, Guido Serini, Giulia Di Pietro, Teresa Cirulli, Francesca Merchionne, Domenico Ribatti, Federico Bussolino, Diego Guidolin, Giovanna Piaggio, Andrea Bacigalupo, Franco Dammacco
Journal: Blood
Blood (2006) 108 (5): 1661–1667.
https://doi.org/10.1182/blood-2006-04-014563
Published: 2006
Includes: Supplemental data